Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

Georges Vauquelin, Sophie Bostoen, Patrick Vanderheyden, Philip Seeman

Onderzoeksoutput: Articlepeer review

66 Citaten (Scopus)


Drug-receptor interactions are traditionally quantified in terms of affinity and efficacy, but there is increasing awareness that the drug-on-receptor residence time also affects clinical performance. While most interest has hitherto been focused on slow-dissociating drugs, D(2) dopamine receptor antagonists show less extrapyramidal side effects but still have excellent antipsychotic activity when they dissociate swiftly. Fast dissociation of clozapine, the prototype of the "atypical antipsychotics", has been evidenced by distinct radioligand binding approaches both on cell membranes and intact cells. The surmountable nature of clozapine in functional assays with fast-emerging responses like calcium transients is confirmatory. Potential advantages and pitfalls of the hitherto used techniques are discussed, and recommendations are given to obtain more precise dissociation rates for such drugs. Surmountable antagonism is necessary to allow sufficient D(2) receptor stimulation by endogenous dopamine in the striatum. Simulations are presented to find out whether this can be achieved during sub-second bursts in dopamine concentration or rather during much slower, activity-related increases thereof. While the antagonist's dissociation rate is important to distinguish between both mechanisms, this becomes much less so when contemplating time intervals between successive drug intakes, i.e., when pharmacokinetic considerations prevail. Attention is also drawn to the divergent residence times of hydrophobic antagonists like haloperidol when comparing radioligand binding data on cell membranes with those on intact cells and clinical data.

Originele taal-2English
Pagina's (van-tot)337-372
Aantal pagina's36
TijdschriftNaunyn-Schmiedeberg's Archives of Pharmacology
Nummer van het tijdschrift4
StatusPublished - apr 2012


Duik in de onderzoeksthema's van 'Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism'. Samen vormen ze een unieke vingerafdruk.

Citeer dit